Guidant Corp.’s VITALITY HE implantable cardioverter defibrillator combines the small, physiologic profile and exceptional longevity with the capacity to deliver more energy to defibrillate the patient. It also provides excellent diagnostics and fast charge times.
The VITALITY HE offers the advanced functionality of the VITALITY family. Recent usage data suggest that more than half of conventional defibrillators implanted in the U.S. today have higher energy output capability.
Technology | June 29, 2006
System Addresses Demand for Defibrillation Energy
Related Content
March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...
March 07, 2023 
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...
February 17, 2023 
Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 29, 2022 
August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is ...
August 19, 2022 
August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...
August 18, 2022 
July 21, 2022 — The global automated external defibrillators market size was valued at USD 717 million in 2021. It is ...
July 22, 2022 
June 10, 2022 — Setting a lower price to enter a competitive market with established brand leaders is a common ...
June 10, 2022 
May 2, 2022 – High-risk patients who need defibrillators to prevent cardiac arrest can experience fewer complications ...
May 02, 2022 
February 14, 2022 — Philips, a global leader in health technology, is supporting the American Heart Association’s multi ...
February 14, 2022 
Feature | Implantable Cardioverter Defibrillator (ICD) | By Dave Fornell, Editor
February 2, 2020 — The U.S. Food and Drug Administration (FDA) has identified a recent recall of the Boston Scientific ...
February 02, 2021 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now